Artificial intelligence and machine learning for improving glycemic control in diabetes: best practices, pitfalls and opportunities.
Journal
IEEE reviews in biomedical engineering
ISSN: 1941-1189
Titre abrégé: IEEE Rev Biomed Eng
Pays: United States
ID NLM: 101493803
Informations de publication
Date de publication:
09 Nov 2023
09 Nov 2023
Historique:
pubmed:
9
11
2023
medline:
9
11
2023
entrez:
9
11
2023
Statut:
aheadofprint
Résumé
Artificial intelligence and machine learning are transforming many fields including medicine. In diabetes, robust biosensing technologies and automated insulin delivery therapies have created a substantial opportunity to improve health. While the number of manuscripts addressing the topic of applying machine learning to diabetes has grown in recent years, there has been a lack of consistency in the methods, metrics, and data used to train and evaluate these algorithms. This manuscript provides consensus guidelines for machine learning practitioners in the field of diabetes, including best practice recommended approaches and warnings about pitfalls to avoid. Algorithmic approaches are reviewed and benefits of different algorithms are discussed including importance of clinical accuracy, explainability, interpretability, and personalization. We review the most common features used in machine learning applications in diabetes glucose control and provide an open-source library of functions for calculating features, as well as a framework for specifying data sets using data sheets. A review of current data sets available for training algorithms is provided as well as an online repository of data sources. These consensus guidelines are designed to improve performance and translatability of new machine learning algorithms developed in the field of diabetes for engineers and data scientists.
Identifiants
pubmed: 37943654
doi: 10.1109/RBME.2023.3331297
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM